Pseudoneurotic schizophrenia: A case report;Esquizofrenia pseudoneurótica: A propósito de un caso

Actas Espanolas de Psiquiatria

Volumn 29, Issue 4, 2001, Pages 275-278

  Vega Dienstmaier, J M ^a,b   Saavedra, J E ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b NONE   (Peru)

Author keywords

Comorbidity; Depression; Panic disorder; Paroxetine; Pseudoneurotic schizophrenia

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; SCHIZOPHRENIA;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PAROXETINE; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS;

EID: 0347871293     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kessler RC. Epidemiology of psychiatric comorbidity. En: Tsuang MT, Tohen M, Zahner GEP, eds. Textbook in psychiatric epidemiology. New York: John Wiley & Sons, Inc; 1995. p. 179-97.
2. Devulder J, De Laat M, Dumoulin K, Renson A, Rolly G. Nightmares and hallucinations after long-term intake of tramadol combined with antidepressants. Acta Clin Belg 1996;51:184-6.
3. Ebert D, Albert R, May A, Merz A, Murata H, Stosiek I, Zahner B. The serotonin syndrome and psychosis-like side-effects of fluvoxamine clinical use-an estimation of incidence. Eur Neuropsychopharmacol 1997;7:71-4.
4. Ismail B, Cantor-Graae E, McNeil TF. Minor physical anomalies in schizophrenic patients and their siblings. Am J Psychiatry 1998;155:1695-702.
5. Mariátegui J. El síndrome fronterizo: problema conceptual, modelos teóricos, ubicación nosográfica. Acta Psiquiat Psicol Amer Lat 1979;25:113-26.
6. Sánchez-García J. Personalidad borderline y narcicista. Lima: Universidad Nacional Mayor de San Marcos; 1996.
7. Saavedra A. Formas atípicas de esquizofrenia. Rev Neuropsiquiatría 1956;19:1-97.
8. Organización Mundial de la Salud. La clasificación de trastornos mentales y del comportamiento CIE-10: descripciones clínicas y pautas para el diagnóstico. Madrid: Organización Mundial de la Salud; 1992.
9. Aono T, Kaneko M, Numata Y, Takahashi Y, Yamamoto T, Kumashiro H. Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia. Folia Psychiatr Neurol Jpn 1981;35:115-21.
10. Argyle N. Panic attacks in chronic schizophrenia. Br J Psychiatry 1990;157:430-3.
11. Cutler JL, Siris SG. «Panic-like» symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications. Compr Psychiatry 1991;32:465-73.
12. Higuchi H, Kamata M, Yoshimoto M, Shimisu T, Hishikawa Y. Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment. Psychiatry Clin Neurosci 1999;53:91-4.
13. Labbate LA, Young PC, Arana GW. Panic disorder in schizophrenia. Can J Psychiatry 1999;44:488-9.
14. Bland RC, Newman SC, Orn H. Schizophrenia: lifetime co-morbidity in a community sample. Acta Psychiatr Scand 1987;75:383-91.
15. Kahn JP, Puertollano MA, Schane MD, Klein DF. Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. Am J Psychiatry 1988;145:742-4.
16. Arlow PB, Moran ME, Bermanzohn PC, Stronger R, Siris SG. Cognitive-behavioral treatment of panic attacks in chronic schizophrenia. J Psychother Pract Res 1997;6:145-50.